Oral health in systemic sclerosis: A scoping review.

Autor:	Gagarine M; Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada.; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada., Cañedo-Ayala M; Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada., Cook V; Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada., Discepola MN; Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada., Guillot G; Sclérodermie Québec, Longueuil, QC, Canada., Leader DM; Department of Comprehensive Care, School of Dental Medicine, Tufts University, Boston, MA, USA.; Department of Public Health and Community Medicine, School of Medicine, Tufts University, Boston, MA, USA., Lim MA; Melbourne Dental School, University of Melbourne, Carlton, VIC, Australia., Yap T; Melbourne Dental School, University of Melbourne, Carlton, VIC, Australia., Furst DE; University of California at Los Angeles, Los Angeles, CA, USA., Gietzen A; Tristate Chapter, National Scleroderma Foundation, Danvers, MA, USA., Lapointe McKenzie JA; Scleroderma Manitoba, Oak Bluff, MB, Canada., Van Pelt S; Washington Evergreen Chapter, National Scleroderma Foundation, Danvers, MA, USA., Vidiricaire L; Sclérodermie Québec, Longueuil, QC, Canada., Carrier ME; Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada., Krishnan A; Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada., Tao L; Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada., Kwakkenbos L; Department of Clinical Psychology, Behavioural Science Institute, Radboud University, Nijmegen, The Netherlands.; Department of IQ Health, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Psychiatry, Radboud University Medical Center, Nijmegen, The Netherlands., Thombs BD; Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada.; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada.; Department of Psychiatry, McGill University, Montreal, QC, Canada.; Department of Medicine, McGill University, Montreal, QC, Canada.; Department of Psychology, McGill University, Montreal, QC, Canada.; Biomedical Ethics Unit, McGill University, Montreal, QC, Canada.
Jazyk:	angličtina
Zdroj:	Journal of scleroderma and related disorders [J Scleroderma Relat Disord] 2024 May 24, pp. 23971983241252899. Date of Electronic Publication: 2024 May 24.
DOI:	10.1177/23971983241252899
Abstrakt:	Background: Limited research on oral health in systematic sclerosis poses a significant challenge for people with systematic sclerosis and health care professionals. We conducted a scoping review to map existing research on oral health-related quality of life in systematic sclerosis across domains including (1) oral manifestations or symptoms, (2) functional consequences, (3) psychosocial aspects, (4) associated patient factors and (5) self-care and management considerations. Methods: We searched MEDLINE, EMBASE, SCOPUS and CINAHL databases to 10 March 2023 for studies on oral health in people with systematic sclerosis. Study data were mapped into pre-specified domains of oral health-related quality of life, subtopics and types of research and reported in tabular form. Results: Of 1460 unique studies reviewed, 91 were eligible and included in the scoping review; of these, 69 (76%) were published as full-text versions, 72 (79%) were from Europe or North America, and 63 (69%) included ⩽50 participants. Only 1 study had >200 participants (N = 382). By domains, 85 (93%) studies reported aspects of oral manifestations or symptoms, with the most common subtopics being oral opening and mandibular function, sicca, periodontitis and soft tissue changes and pathology; 36 (40%) studies provided information on associated patient factors, 23 (25%) on self-care and management, 19 (21%) on psychosocial aspects and 6 (7%) on functional consequences. No studies related to interventions included >50 participants. Conclusion: Most studies on oral health in systematic sclerosis report on manifestations or symptoms, and there are relatively few studies on other important domains. Most studies have been conducted with small samples. Updated systematic reviews should evaluate the quality of existing evidence in domains where enough studies have been done. Large, well-conducted primary studies are needed to address knowledge gaps across domains, including studies that test approaches for supporting oral self-care, improving routine professional care and addressing major disability-causing manifestations. Competing Interests: The author(s) declared the following potential conflicts of interest with respect to the research, authorship and/or publication of this article: All authors have completed the ICMJE’s conflicts of interest disclosure form. D.M.L. declares that he advises and holds stock in ClearQuest Naturals, Inc. All other authors declare: no support from any organization for the submitted work; no financial relationships with any organizations that might have an interest in the submitted work in the previous 3 years, and no other relationships or activities that could appear to have influenced the submitted work. (© The Author(s) 2024.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu